#23 - Genotypic Resistance to Integrase Inhibitors, Protease Inhibitors and Tenofovir Alafenamide Is Uncommon in Children With Virological Rebound in the CHAPAS-4 Randomised Trial of Second-Line Antiretroviral Therapy for Children With HIV - Cissy Kityo

Video